Bococizumab is a remarkable anti-PCSK9 antibody efficiently developed to combat hypercholesterolemia. It therapeutic agent functions through the PCSK9 protein, a essential regulator of cholesterol amounts. By https://mediajx.com/story27573707/bococizumab-a-novel-anti-pcsk9-antibody-for-hypercholesterolemia